{30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack

RxCUI
1792392
RxNorm name
{30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack
Display name
{30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack
Full name
{30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f4bedd21-efde-44c6-9d9c-b48b78d7ed1e{30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack [GPCK] · lenvatinib 18 MG Daily Dose 30 Day Supply Pack [PSN] · lenvatinib 14 MG (as lenvatinib mesylate) Daily Dose 30 Day Supply Pack [SY]378These highlights do not include all the information needed to use LENVIMA safely and effectively. See full prescribing information for LENVIMA . LENVIMA ® ( lenvatinib ) capsules , for oral use Initial U.S. Approval: 201520250103